Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
- PMID: 35908561
- PMCID: PMC9333997
- DOI: 10.1016/S0140-6736(22)01295-8
Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
Comment on
-
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.Lancet. 2022 Jul 30;400(10349):359-368. doi: 10.1016/S0140-6736(22)01109-6. Lancet. 2022. PMID: 35908569 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
